DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
Ubicación actual:
> This Story

Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment




Molecular Imaging Homepage

US suppliers to join the Mo-99 market, high-energy materials gaining traction Radiopharmaceutical supply chain update

Navigating the molecular imaging market Purchasing insights from the experts at MD Buyline

Assessing the state of Alzheimer’s imaging The battle against neuro-degenerative disease wages on

Absolute Imaging Solutions acquires Northeast Electronics Facilitates push into East Coast market

Eden Radioisotopes scores funding for isotope reactor production Will primarily produce Mo-99

SHINE secures rights to new method for Lutetium-177 production Generate Lu-177 at greater speed and scale

FDA gives green light to new United Imaging PET/MR scanner The uPMR 790 HD TOF performs total-body scans within 20 minutes

FDA reminder for properly eluting rubidium 82 generators prompted by 'recent incidents' Using incorrect solutions puts patients at risk

Generating higher quality PET images 100x faster at MSK 'No one has done PET imaging in this way before'

PET uncovers abnormal tau deposits associated with CTE in live subjects May enable diagnosis of CTE in living people one day

Center for Molecular Imaging and
Therapy (CMIT)

Louisiana getting $14 million Center for Molecular Imaging and Therapy

por John R. Fischer , Staff Reporter
Louisiana’s Biomedical Research Foundation (BRF) is adding 20,000 square feet to its premises with the construction of a new Center for Molecular Imaging and Therapy (CMIT).

Located in Shreveport, the $14.2 million facility will be home to an assortment of radiopharmaceutical equipment and operations, as well as patient imaging services, and a clinical and translational research program. Leading the program will be executive director Dr. Pradeep K. Garg, a molecular imaging researcher with experience heading programs at Yale, Wake Forest and Duke Universities, and a developer of disease-specific novel radiopharmaceuticals.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

"CMIT will purchase a new cyclotron and related equipment such as hot cells, synthesis modules, and a dose dispensing station," Dr. Pradeep K. Garg, executive director of Center for Molecular Imaging and Therapy, told HCB News. "New capabilities include increasing the range and variety of radioisotopes and radiopharmaceuticals."

“Molecular imaging is an invaluable tool that improves disease diagnosis as well as management and treatment of such diseases as cancer, dementias, and heart disease,” he said in a statement. “Targeted radiopharmaceuticals produced by CMIT will help diagnose diseases more precisely, and accurately and will help physicians in choosing more effective treatment options and guide better outcomes for patients.”

The program is an evolution of BRF’s PET Imaging Center, which opened in 1995 as Louisiana’s first molecular imaging scanning and radiopharmaceutical production facility, and was one of the first full-service, nonacademic centers in the country. It serves more than 46,000 patients, making it one of the most active centers in the Southern U.S.

In addition to adding approximately 25 new skilled jobs, the center will improve access for referring physicians in North Louisiana, East Texas and South Arkansas; enable earlier diagnoses and modified treatments; increase clinical, research and commercialization impacts for the state; and create a pipeline of intellectual properly and novel radiopharmaceutical patents for healthcare startups.

It also is expected to open up research opportunities for radiopharmaceutical and radiochemistry collaborations; drug discovery and development processes; higher education collaborations, including with the LSU Health Sciences Center Shreveport; preclinical basic science endeavors; and expanded clinical trials.

To assist in construction, the Bayou State has issued a performance-based grant of $1 million to offset the cost of building expenses and medical production equipment. The addition of these devices will enable CMIT to increase its array of novel radiopharmaceuticals for applications in cardiovascular disease; prostate, pancreatic and other cancers; Alzheimer’s disease and related dementias; and hyperinsulinism, among other conditions.

"The world-wide market for novel diagnostic and therapeutic radiopharmaceuticals is expected to reach $7.4 billion by 2024, according to Transparency Market Research," said Garg. "The expanded program at the new CMIT is expected to offer more opportunities for radiopharmaceutical and radiochemistry research collaboration, pre-clinical basic science research and involvement in the drug discovery and development process, which can attract and retain talent. It will also enhance research collaborations with higher educational institutions and expand clinical trial opportunities for patients, bringing cutting edge diagnostic and therapeutic options to patients and improving access for referring physicians in North Louisiana, East Texas and South Arkansas."

The global market for novel diagnostic and therapeutic radiopharmaceuticals is estimated to reach $7.4 billion by 2024.

BRF, the BRF board and leadership have raised $9.4 million for the project to date. The remaining cost will be raised by private and public sources.

The center is expected to open in 2020.

Molecular Imaging Homepage

You Must Be Logged In To Post A Comment

Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Recently Certified
Ver usuarios certificados recientemente
Recently Rated
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Service Technicians Forum
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2019, Inc.